Hepion Pharmaceuticals Inc (HEPA)
1.21
+0.04
(+3.42%)
USD |
NASDAQ |
May 21, 16:00
1.21
0.00 (0.00%)
After-Hours: 16:50
Hepion Pharmaceuticals Enterprise Value: -6.688M for May 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 20, 2024 | -6.688M |
| May 17, 2024 | -5.976M |
| May 16, 2024 | -6.305M |
| May 15, 2024 | -6.797M |
| May 14, 2024 | -6.031M |
| May 13, 2024 | -6.469M |
| May 10, 2024 | -6.195M |
| May 09, 2024 | -5.922M |
| May 08, 2024 | -5.922M |
| May 07, 2024 | -5.593M |
| May 06, 2024 | -5.539M |
| May 03, 2024 | -5.101M |
| May 02, 2024 | -4.773M |
| May 01, 2024 | -5.648M |
| April 30, 2024 | -5.621M |
| April 29, 2024 | -5.593M |
| April 26, 2024 | -5.593M |
| April 25, 2024 | -6.031M |
| April 24, 2024 | -5.867M |
| April 23, 2024 | -4.937M |
| April 22, 2024 | -5.374M |
| April 19, 2024 | -2.091M |
| April 18, 2024 | -1.534M |
| April 17, 2024 | -1.434M |
| April 16, 2024 | -1.927M |
| Date | Value |
|---|---|
| April 15, 2024 | -1.161M |
| April 12, 2024 | -1.106M |
| April 11, 2024 | -0.8871M |
| April 10, 2024 | -0.6135M |
| April 09, 2024 | 0.2621M |
| April 08, 2024 | 0.9188M |
| April 05, 2024 | 0.6999M |
| April 04, 2024 | 1.357M |
| April 03, 2024 | 0.9188M |
| April 02, 2024 | -0.5587M |
| April 01, 2024 | -0.1757M |
| March 28, 2024 | 0.5358M |
| March 27, 2024 | 0.5905M |
| March 26, 2024 | -0.3946M |
| March 25, 2024 | -0.7776M |
| March 22, 2024 | -0.2304M |
| March 21, 2024 | -0.3946M |
| March 20, 2024 | -0.2851M |
| March 19, 2024 | -1.434M |
| March 18, 2024 | -1.161M |
| March 15, 2024 | -0.7229M |
| March 14, 2024 | -1.927M |
| March 13, 2024 | -1.653M |
| March 12, 2024 | -2.586M |
| March 11, 2024 | -2.297M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-36.74M
Minimum
Dec 28 2022
109.04M
Maximum
Mar 25 2021
3.573M
Average
1.568M
Median
Oct 05 2023
Enterprise Value Benchmarks
| Ionis Pharmaceuticals Inc | 4.721B |
| Madrigal Pharmaceuticals Inc | 4.003B |
| Galectin Therapeutics Inc | 257.52M |
| Viking Therapeutics Inc | 6.482B |
| 89bio Inc | 342.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.06M |
| Total Expenses (Quarterly) | 7.219M |
| EPS Diluted (Quarterly) | -2.42 |
| Earnings Yield | -1.02K% |